Clavio, Marino <br/><br/>
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.  [electronic resource] 

 -  Oncology reports  Oct 2005 
 - 933-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1021-335X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, CD34--biosynthesis<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carmustine--administration & dosage<br/>Cytarabine--administration & dosage<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Multiple Myeloma--drug therapy<br/>Odds Ratio<br/>Peripheral Blood Stem Cell Transplantation--methods<br/>Podophyllotoxin--administration & dosage<br/>Recurrence<br/>Remission Induction<br/>Salvage Therapy--methods<br/>Time Factors<br/>Transplantation Conditioning--methods<br/>Treatment Outcome